Assenagon Asset Management S.A. Aclaris Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

  • $60.5 Billion
  • Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 184,585 shares of ACRS stock, worth $313,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184,585
Previous 681,553 72.92%
Holding current value
$313,794
Previous $1.04 Million 74.86%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 11, 2025
SELL
$1.08 - $1.63 $536,725 - $810,057
-496,968 Reduced 72.92%
184,585 $262,000
Q1 2025

Apr 15, 2025
BUY
$1.53 - $2.6 $434,812 - $738,896
284,191 Added 71.52%
681,553 $1.04 Million
Q4 2024

Jan 14, 2025
BUY
$1.15 - $4.59 $243,322 - $971,175
211,585 Added 113.89%
397,362 $985,000
Q3 2024

Oct 23, 2024
BUY
$1.12 - $1.4 $208,070 - $260,087
185,777 New
185,777 $209,000
Q3 2023

Nov 06, 2023
BUY
$6.56 - $10.95 $330,007 - $550,850
50,306 Added 7.9%
687,135 $4.71 Million
Q2 2023

Jul 25, 2023
BUY
$7.89 - $10.64 $1.66 Million - $2.25 Million
211,001 Added 49.55%
636,829 $6.6 Million
Q1 2023

Apr 18, 2023
BUY
$7.07 - $17.95 $1.63 Million - $4.14 Million
230,905 Added 118.46%
425,828 $3.44 Million
Q3 2022

Oct 27, 2022
SELL
$13.07 - $18.22 $1.28 Million - $1.79 Million
-98,122 Reduced 33.48%
194,923 $3.07 Million
Q2 2022

Jul 27, 2022
SELL
$10.16 - $17.08 $2.18 Million - $3.66 Million
-214,390 Reduced 42.25%
293,045 $4.09 Million
Q1 2022

Apr 25, 2022
BUY
$9.74 - $17.92 $4.94 Million - $9.09 Million
507,435 New
507,435 $8.75 Million
Q4 2021

Feb 01, 2022
SELL
$12.27 - $18.49 $5.81 Million - $8.75 Million
-473,365 Closed
0 $0
Q3 2021

Oct 19, 2021
SELL
$13.38 - $18.8 $1.38 Million - $1.95 Million
-103,507 Reduced 17.94%
473,365 $8.52 Million
Q2 2021

Jul 15, 2021
BUY
$17.08 - $29.6 $9.5 Million - $16.5 Million
556,283 Added 2701.85%
576,872 $10.1 Million
Q1 2021

Apr 26, 2021
BUY
$5.86 - $27.73 $120,651 - $570,932
20,589 New
20,589 $519,000
Q3 2019

Oct 16, 2019
SELL
$0.79 - $2.47 $65,494 - $204,775
-82,905 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$2.13 - $7.06 $176,587 - $585,309
82,905 New
82,905 $182,000
Q1 2019

Apr 26, 2019
SELL
$5.63 - $7.84 $681,291 - $948,726
-121,011 Closed
0 $0
Q4 2018

Jan 23, 2019
BUY
$6.3 - $15.4 $762,369 - $1.86 Million
121,011 New
121,011 $894,000

Others Institutions Holding ACRS

# of Institutions
112
Shares Held
92.4M
Call Options Held
35.4K
Put Options Held
32K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $113M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email